RSS-Feed abonnieren
DOI: 10.1055/s-0039-1700996
Pulmonary Langerhans Cell Histiocytosis
Publikationsverlauf
Publikationsdatum:
12. April 2020 (online)
![](https://www.thieme-connect.de/media/srccm/202002/lookinside/thumbnails/10-1055-s-0039-1700996_01562-1.jpg)
Abstract
Pulmonary Langerhans cell histiocytosis (PLCH) is a diffuse cystic lung disease that is strongly associated with exposure to cigarette smoke. Recently, activating pathogenic mutations in the mitogen-activated protein kinase pathway have been described in the dendritic cells in patients with PLCH and have firmly established PLCH to be an inflammatory myeloid neoplasm. Disease course and prognosis in PLCH are highly variable among individual patients, ranging from spontaneous resolution to development of pulmonary hypertension and progression to terminal respiratory failure. A subset of patients with PLCH may have extrapulmonary involvement, typically involving the skeletal system in the form of lytic lesions, skin lesions, or the central nervous system most commonly manifesting in the form of diabetes insipidus. Smoking cessation is the cornerstone of treatment in patients with PLCH and can lead to disease regression or stabilization in a substantial proportion of patients. Further insight into the underlying molecular pathogenesis of PLCH has paved the way for the future development of disease-specific biomarkers and targeted treatment options directed against the central disease-driving mutations.
-
References
- 1 Wei P, Lu HW, Jiang S, Fan LC, Li HP, Xu JF. Pulmonary Langerhans cell histiocytosis: case series and literature review. Medicine (Baltimore) 2014; 93 (23) e141
- 2 Emile JF, Abla O, Fraitag S. , et al; Histiocyte Society. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 2016; 127 (22) 2672-2681
- 3 Delobbe A, Durieu J, Duhamel A, Wallaert B. Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). Groupe d'Etude en Pathologie Interstitielle de la Société de Pathologie Thoracique du Nord. Eur Respir J 1996; 9 (10) 2002-2006
- 4 Tazi A. Adult pulmonary Langerhans' cell histiocytosis. Eur Respir J 2006; 27 (06) 1272-1285
- 5 Vassallo R, Ryu JH, Schroeder DR, Decker PA, Limper AH. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med 2002; 346 (07) 484-490
- 6 Basset F, Corrin B, Spencer H. , et al. Pulmonary histiocytosis X. Am Rev Respir Dis 1978; 118 (05) 811-820
- 7 Crausman RS, Jennings CA, Tuder RM, Ackerson LM, Irvin CG, King Jr TE. Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. Am J Respir Crit Care Med 1996; 153 (01) 426-435
- 8 Friedman PJ, Liebow AA, Sokoloff J. Eosinophilic granuloma of lung. Clinical aspects of primary histiocytosis in the adult. Medicine (Baltimore) 1981; 60 (06) 385-396
- 9 Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmonson JH, Schomberg PJ. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer 1999; 85 (10) 2278-2290
- 10 Schönfeld N, Frank W, Wenig S. , et al. Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X. Respiration 1993; 60 (01) 38-44
- 11 Travis WD, Borok Z, Roum JH. , et al. Pulmonary Langerhans cell granulomatosis (histiocytosis X). A clinicopathologic study of 48 cases. Am J Surg Pathol 1993; 17 (10) 971-986
- 12 Watanabe R, Tatsumi K, Hashimoto S, Tamakoshi A, Kuriyama T. ; Respiratory Failure Research Group of Japan. Clinico-epidemiological features of pulmonary histiocytosis X. Intern Med 2001; 40 (10) 998-1003
- 13 Haupt R, Minkov M, Astigarraga I. , et al; Euro Histio Network. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer 2013; 60 (02) 175-184
- 14 Vassallo R, Harari S, Tazi A. Current understanding and management of pulmonary Langerhans cell histiocytosis. Thorax 2017; 72 (10) 937-945
- 15 Kim T, Kwon HJ, Eom M, Kim SW, Sin MH, Jung SH. Bronchial washing cytology of pulmonary Langerhans cell histiocytosis: a case report. J Pathol Transl Med 2017; 51 (04) 444-447
- 16 Juvet SC, Hwang D, Downey GP. Rare lung diseases III: pulmonary Langerhans' cell histiocytosis. Can Respir J 2010; 17 (03) e55-e62
- 17 Gaensler EA, Carrington CB. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients. Ann Thorac Surg 1980; 30 (05) 411-426
- 18 Lorillon G, Tazi A. How I manage pulmonary Langerhans cell histiocytosis. Eur Respir Rev 2017; 26 (145) 170070
- 19 Thomeer M, Demedts M, Vandeurzen K. ; VRGT Working Group on Interstitial Lung Diseases. Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders. Acta Clin Belg 2001; 56 (03) 163-172
- 20 Nagarjun Rao R, Chang CC, Tomashefski Jr JF. Lymphocyte sub-populations and non-Langerhans' cell monocytoid cells in pulmonary Langerhans' cell histiocytosis. Pathol Res Pract 2008; 204 (05) 315-322
- 21 Ito T, Carson IV WF, Cavassani KA, Connett JM, Kunkel SL. CCR6 as a mediator of immunity in the lung and gut. Exp Cell Res 2011; 317 (05) 613-619
- 22 Sallusto F, Schaerli P, Loetscher P. , et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 1998; 28 (09) 2760-2769
- 23 Worbs T, Hammerschmidt SI, Förster R. Dendritic cell migration in health and disease. Nat Rev Immunol 2017; 17 (01) 30-48
- 24 Botelho FM, Nikota JK, Bauer CM. , et al. Cigarette smoke-induced accumulation of lung dendritic cells is interleukin-1α-dependent in mice. Respir Res 2012; 13: 81
- 25 Demedts IK, Bracke KR, Van Pottelberge G. , et al. Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175 (10) 998-1005
- 26 Lommatzsch M, Bratke K, Knappe T. , et al. Acute effects of tobacco smoke on human airway dendritic cells in vivo. Eur Respir J 2010; 35 (05) 1130-1136
- 27 Tsoumakidou M, Demedts IK, Brusselle GG, Jeffery PK. Dendritic cells in chronic obstructive pulmonary disease: new players in an old game. Am J Respir Crit Care Med 2008; 177 (11) 1180-1186
- 28 Annels NE, Da Costa CE, Prins FA, Willemze A, Hogendoorn PC, Egeler RM. Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis. J Exp Med 2003; 197 (10) 1385-1390
- 29 Castoldi MC, Verrioli A, De Juli E, Vanzulli A. Pulmonary Langerhans cell histiocytosis: the many faces of presentation at initial CT scan. Insights Imaging 2014; 5 (04) 483-492
- 30 Leatherwood DL, Heitkamp DE, Emerson RE. Best cases from the AFIP: pulmonary Langerhans cell histiocytosis. Radiographics 2007; 27 (01) 265-268
- 31 Stone S, Lynch D. National Jewish Health classical pulmonary radiology case reports: imaging features of Langerhans cell histiocytosis. QJM 2018; 111 (10) 739-740
- 32 Geissmann F, Lepelletier Y, Fraitag S. , et al. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 2001; 97 (05) 1241-1248
- 33 de Graaf JH, Tamminga RY, Dam-Meiring A, Kamps WA, Timens W. The presence of cytokines in Langerhans' cell histiocytosis. J Pathol 1996; 180 (04) 400-406
- 34 Hayashi T, Rush WL, Travis WD, Liotta LA, Stetler-Stevenson WG, Ferrans VJ. Immunohistochemical study of matrix metalloproteinases and their tissue inhibitors in pulmonary Langerhans' cell granulomatosis. Arch Pathol Lab Med 1997; 121 (09) 930-937
- 35 Bernstrand C, Cederlund K, Sandstedt B. , et al. Pulmonary abnormalities at long-term follow-up of patients with Langerhans cell histiocytosis. Med Pediatr Oncol 2001; 36 (04) 459-468
- 36 Hashimoto M, Yanagisawa H, Minagawa S. , et al. TGF-β-dependent dendritic cell chemokinesis in murine models of airway disease. J Immunol 2015; 195 (03) 1182-1190
- 37 Soler P, Moreau A, Basset F, Hance AJ. Cigarette smoking-induced changes in the number and differentiated state of pulmonary dendritic cells/Langerhans cells. Am Rev Respir Dis 1989; 139 (05) 1112-1117
- 38 Vassallo R, Walters PR, Lamont J, Kottom TJ, Yi ES, Limper AH. Cigarette smoke promotes dendritic cell accumulation in COPD; a Lung Tissue Research Consortium study. Respir Res 2010; 11: 45
- 39 Bracke KR, D'hulst AI, Maes T. , et al. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. J Immunol 2006; 177 (07) 4350-4359
- 40 Marchal J, Kambouchner M, Tazi A, Valeyre D, Soler P. Expression of apoptosis-regulatory proteins in lesions of pulmonary Langerhans cell histiocytosis. Histopathology 2004; 45 (01) 20-28
- 41 Prasse A, Stahl M, Schulz G. , et al. Essential role of osteopontin in smoking-related interstitial lung diseases. Am J Pathol 2009; 174 (05) 1683-1691
- 42 Reibman J, Hsu Y, Chen LC, Bleck B, Gordon T. Airway epithelial cells release MIP-3alpha/CCL20 in response to cytokines and ambient particulate matter. Am J Respir Cell Mol Biol 2003; 28 (06) 648-654
- 43 Yousem SA, Colby TV, Chen YY, Chen WG, Weiss LM. Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol 2001; 25 (05) 630-636
- 44 Willman CL, Busque L, Griffith BB. , et al. Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative disease. N Engl J Med 1994; 331 (03) 154-160
- 45 Willman CL, McClain KL. An update on clonality, cytokines, and viral etiology in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998; 12 (02) 407-416
- 46 Yu RC, Chu C, Buluwela L, Chu AC. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 1994; 343 (8900): 767-768
- 47 Eroglu Z, Ribas A. Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy. Ther Adv Med Oncol 2016; 8 (01) 48-56
- 48 Durham BH, Getta B, Dietrich S. , et al. Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations. Blood 2017; 130 (14) 1644-1648
- 49 Kim WW, Ha TK, Bae SK. Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis. J Otolaryngol Head Neck Surg 2018; 47 (01) 4
- 50 Allen CE, Parsons DW. Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders. Hematology (Am Soc Hematol Educ Program) 2015; 2015: 559-564
- 51 Mourah S, How-Kit A, Meignin V. , et al. Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis. Eur Respir J 2016; 47 (06) 1785-1796
- 52 Roden AC, Yi ES. Pulmonary Langerhans cell histiocytosis: an update from the pathologists' perspective. Arch Pathol Lab Med 2016; 140 (03) 230-240
- 53 Brabencova E, Tazi A, Lorenzato M. , et al. Langerhans cells in Langerhans cell granulomatosis are not actively proliferating cells. Am J Pathol 1998; 152 (05) 1143-1149
- 54 Senechal B, Elain G, Jeziorski E. , et al. Expansion of regulatory T cells in patients with Langerhans cell histiocytosis. PLoS Med 2007; 4 (08) e253
- 55 Caffrey PR, Altman RS. Pulmonary alveolar microlitbiasis occurring in premature twins. J Pediatr 1965; 66: 758-763
- 56 Chilosi M, Facchetti F, Caliò A. , et al. Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis. Leuk Lymphoma 2014; 55 (11) 2620-2626
- 57 Knudson Jr AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971; 68 (04) 820-823
- 58 Singla A, Kopras EJ, Gupta N. Spontaneous pneumothorax and air travel in Pulmonary Langerhans cell histiocytosis: a patient survey. Respir Investig 2019; S2212-5345(19)30148-0
- 59 Colby TV, Lombard C. Histiocytosis X in the lung. Hum Pathol 1983; 14 (10) 847-856
- 60 Minghini A, Trogdon SD. Recurrent spontaneous pneumothorax in pulmonary histiocytosis X. Am Surg 1998; 64 (11) 1040-1042
- 61 Mendez JL, Nadrous HF, Vassallo R, Decker PA, Ryu JH. Pneumothorax in pulmonary Langerhans cell histiocytosis. Chest 2004; 125 (03) 1028-1032
- 62 Fartoukh M, Humbert M, Capron F. , et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000; 161 (01) 216-223
- 63 Harari S, Brenot F, Barberis M, Simmoneau G. Advanced pulmonary histiocytosis X is associated with severe pulmonary hypertension. Chest 1997; 111 (04) 1142-1144
- 64 Vassallo R, Ryu JH, Colby TV, Hartman T, Limper AH. Pulmonary Langerhans'-cell histiocytosis. N Engl J Med 2000; 342 (26) 1969-1978
- 65 Abbott GF, Rosado-de-Christenson ML, Franks TJ, Frazier AA, Galvin JR. From the archives of the AFIP: pulmonary Langerhans cell histiocytosis. Radiographics 2004; 24 (03) 821-841
- 66 Lacronique J, Roth C, Battesti JP, Basset F, Chretien J. Chest radiological features of pulmonary histiocytosis X: a report based on 50 adult cases. Thorax 1982; 37 (02) 104-109
- 67 Brauner MW, Grenier P, Tijani K, Battesti JP, Valeyre D. Pulmonary Langerhans cell histiocytosis: evolution of lesions on CT scans. Radiology 1997; 204 (02) 497-502
- 68 Brauner MW, Grenier P, Mouelhi MM, Mompoint D, Lenoir S. Pulmonary histiocytosis X: evaluation with high-resolution CT. Radiology 1989; 172 (01) 255-258
- 69 Seely JM, Salahudeen Sr S, Cadaval-Goncalves AT. , et al. Pulmonary Langerhans cell histiocytosis: a comparative study of computed tomography in children and adults. J Thorac Imaging 2012; 27 (01) 65-70
- 70 Tazi A, de Margerie C, Naccache JM. , et al. The natural history of adult pulmonary Langerhans cell histiocytosis: a prospective multicentre study. Orphanet J Rare Dis 2015; 10: 30
- 71 Thurlbeck WM, Churg A. Thurlbeck's Pathology of the Lung, 3rd ed. New York: Thieme; 2005
- 72 Lieberman PH, Jones CR, Steinman RM. , et al. Langerhans cell (eosinophilic) granulomatosis. A clinicopathologic study encompassing 50 years. Am J Surg Pathol 1996; 20 (05) 519-552
- 73 Kambouchner M, Basset F, Marchal J, Uhl JF, Hance AJ, Soler P. Three-dimensional characterization of pathologic lesions in pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med 2002; 166 (11) 1483-1490
- 74 Emile JF, Wechsler J, Brousse N. , et al. Langerhans' cell histiocytosis. Definitive diagnosis with the use of monoclonal antibody O10 on routinely paraffin-embedded samples. Am J Surg Pathol 1995; 19 (06) 636-641
- 75 Mogulkoc N, Veral A, Bishop PW, Bayindir U, Pickering CA, Egan JJ. Pulmonary Langerhans' cell histiocytosis: radiologic resolution following smoking cessation. Chest 1999; 115 (05) 1452-1455
- 76 Tazi A, Montcelly L, Bergeron A, Valeyre D, Battesti JP, Hance AJ. Relapsing nodular lesions in the course of adult pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med 1998; 157 (6 Pt 1): 2007-2010
- 77 Von Essen S, West W, Sitorius M, Rennard SI. Complete resolution of roentgenographic changes in a patient with pulmonary histiocytosis X. Chest 1990; 98 (03) 765-767
- 78 Tazi A, Lorillon G, Haroche J. , et al. Vinblastine chemotherapy in adult patients with Langerhans cell histiocytosis: a multicenter retrospective study. Orphanet J Rare Dis 2017; 12 (01) 95
- 79 Goh NS, McDonald CE, MacGregor DP, Pretto JJ, Brodie GN. Successful treatment of Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. Respirology 2003; 8 (01) 91-94
- 80 Pardanani A, Phyliky RL, Li CY, Tefferi A. 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis. Mayo Clin Proc 2003; 78 (03) 301-306
- 81 Saven A, Burian C. Cladribine activity in adult Langerhans-cell histiocytosis. Blood 1999; 93 (12) 4125-4130
- 82 Aerni MR, Aubry MC, Myers JL, Vassallo R. Complete remission of nodular pulmonary Langerhans cell histiocytosis lesions induced by 2-chlorodeoxyadenosine in a non-smoker. Respir Med 2008; 102 (02) 316-319
- 83 Epaud R, Ducou Le Pointe H, Fasola S. , et al. Cladribine improves lung cysts and pulmonary function in a child with histiocytosis. Eur Respir J 2015; 45 (03) 831-833
- 84 Grobost V, Khouatra C, Lazor R, Cordier JF, Cottin V. Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis. Orphanet J Rare Dis 2014; 9: 191
- 85 Lazor R, Etienne-Mastroianni B, Khouatra C, Tazi A, Cottin V, Cordier JF. Progressive diffuse pulmonary Langerhans cell histiocytosis improved by cladribine chemotherapy. Thorax 2009; 64 (03) 274-275
- 86 Lorillon G, Bergeron A, Detourmignies L. , et al. Cladribine is effective against cystic pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med 2012; 186 (09) 930-932
- 87 Weitzman S, Braier J, Donadieu J. , et al. 2′-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). Results of the LCH-S-98 protocol of the Histiocyte Society. Pediatr Blood Cancer 2009; 53 (07) 1271-1276
- 88 Diamond EL, Subbiah V, Lockhart AC. , et al. Vemurafenib for BRAF V600-mutant Erdheim-Chester disease and Langerhans cell histiocytosis: analysis of data from the histology-independent, phase 2, open-label VE-BASKET study. JAMA Oncol 2018; 4 (03) 384-388
- 89 Diamond EL, Durham BH, Ulaner GA. , et al. Efficacy of MEK inhibition in patients with histiocytic neoplasms. Nature 2019; 567 (7749): 521-524
- 90 Lorillon G, Jouenne F, Baroudjian B. , et al. Response to trametinib of a pulmonary Langerhans cell histiocytosis harboring a MAP2K1 deletion. Am J Respir Crit Care Med 2018; 198 (05) 675-678
- 91 Radzikowska E, Błasińska-Przerwa K, Wiatr E, Bestry I, Langfort R, Roszkowski-Śliż K. Pneumothorax in patients with pulmonary Langerhans cell histiocytosis. Lung 2018; 196 (06) 715-720
- 92 DiMaggio LA, Lippes HA, Lee RV. Histiocytosis X and pregnancy. Obstet Gynecol 1995; 85 (5 Pt 2): 806-809
- 93 King Jr TE. Restrictive lung disease in pregnancy. Clin Chest Med 1992; 13 (04) 607-622
- 94 Boehler A. Lung transplantation for cystic lung diseases: lymphangioleiomyomatosis, histiocytosis x, and sarcoidosis. Semin Respir Crit Care Med 2001; 22 (05) 509-516
- 95 Etienne B, Bertocchi M, Gamondes JP. , et al. Relapsing pulmonary Langerhans cell histiocytosis after lung transplantation. Am J Respir Crit Care Med 1998; 157 (01) 288-291
- 96 Gabbay E, Dark JH, Ashcroft T. , et al. Recurrence of Langerhans' cell granulomatosis following lung transplantation. Thorax 1998; 53 (04) 326-327
- 97 Habib SB, Congleton J, Carr D. , et al. Recurrence of recipient Langerhans' cell histiocytosis following bilateral lung transplantation. Thorax 1998; 53 (04) 323-325
- 98 Sulica R, Teirstein A, Padilla ML. Lung transplantation in interstitial lung disease. Curr Opin Pulm Med 2001; 7 (05) 314-322
- 99 Dauriat G, Mal H, Thabut G. , et al. Lung transplantation for pulmonary Langerhans' cell histiocytosis: a multicenter analysis. Transplantation 2006; 81 (05) 746-750
- 100 Wajda N, Zhu Z, Jandarov R, Dilling DF, Gupta N. Clinical outcomes and survival following lung transplantation in patients with pulmonary Langerhans cell histiocytosis. Respirology 2019
- 101 Girschikofsky M, Arico M, Castillo D. , et al. Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net. Orphanet J Rare Dis 2013; 8: 72
- 102 Suri HS, Yi ES, Nowakowski GS, Vassallo R. Pulmonary Langerhans cell histiocytosis. Orphanet J Rare Dis 2012; 7: 16
- 103 Tazi A, Soler P, Hance AJ. Adult pulmonary Langerhans' cell histiocytosis. Thorax 2000; 55 (05) 405-416